Protection of the Human Gut Microbiome From Antibiotics/Experiment 1/Signature 2

From BugSigDB
Needs review

Curated date: 2021/01/10

Curator: Mst Afroza Parvin

Revision editor(s): Lwaldron, WikiWorks

Source: Supplementary table 3, Supplementary figure 1

Description: A detailed analysis of the MGSs that differed significantly between treatment groups

Abundance in Group 1: decreased abundance in moxifloxacin treated group (MXF)

NCBI Quality ControlLinks
Alistipes
Alistipes finegoldii
Alistipes onderdonkii
Alistipes putredinis
Alistipes shahii
Bacteroidales
Barnesiella intestinihominis
Bifidobacterium adolescentis
Bifidobacterium pseudocatenulatum
Bilophila wadsworthia
Blautia
Blautia sp.
Butyricimonas
Butyricimonas virosa
Catenibacterium
Cloacibacterium sp.
Clostridium
Clostridium sp.
Coprobacillus
Dorea formicigenerans
Eubacteriales
Eubacterium
Faecalibacterium
Faecalibacterium prausnitzii
Bacillota
Haemophilus parainfluenzae
Intestinibacter bartlettii
Lachnospira eligens
Lachnospiraceae
Odoribacter splanchnicus
Oscillibacter
Oscillibacter sp.
Oscillospiraceae
Parabacteroides distasonis
Parasutterella excrementihominis
Roseburia inulinivorans
Ruminococcus callidus
Streptococcus parasanguinis

Revision editor(s): Lwaldron, WikiWorks